Heath A. Smith
AbbVie (United States)(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, Peptidase Inhibition and Analysis, vaccines and immunoinformatics approaches
Most-Cited Works
- → The metastasis-promoting roles of tumor-associated immune cells(2013)364 cited
- → MTDH-SND1 Interaction Is Crucial for Expansion and Activity of Tumor-Initiating Cells in Diverse Oncogene- and Carcinogen-Induced Mammary Tumors(2014)135 cited
- → Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer(2011)101 cited
- → Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a–LCOR axis(2017)101 cited
- → The SSX Family of Cancer‐Testis Antigens as Target Proteins for Tumor Therapy(2010)95 cited
- → PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope–Modified DNA Vaccine Immunization(2015)78 cited
- → Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer(2021)76 cited
- → Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis(2021)70 cited
- → Expression and Immunotherapeutic Targeting of the SSX Family of Cancer–Testis Antigens in Prostate Cancer(2011)58 cited
- → Determinants of Organotropic Metastasis(2016)41 cited